LncRNA ANRIL Expression and ANRIL Gene Polymorphisms Contribute to the Risk of Ischemic Stroke in the Chinese Han Population

[1]  Xiaobo Yang,et al.  Pathophysiology of Long Non-coding RNAs in Ischemic Stroke , 2018, Front. Mol. Neurosci..

[2]  Zhong-Ping Feng,et al.  Long non-coding RNAs in ischemic stroke , 2018, Cell Death & Disease.

[3]  C. Beyer,et al.  Brain inflammasomes in stroke and depressive disorders: Regulation by oestrogen , 2018, Journal of neuroendocrinology.

[4]  J. Mendell,et al.  Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.

[5]  T. Uejima,et al.  Effects of Smoking on Ischemic Stroke, Intracranial Hemorrhage, and Coronary Artery Events in Japanese Patients With Non-Valvular Atrial Fibrillation. , 2017, International heart journal.

[6]  G. Danaei,et al.  Impact of level and patterns of alcohol drinking on coronary heart disease and stroke burden in Argentina , 2017, PloS one.

[7]  Xinguang Liu,et al.  Variants in ANRIL gene correlated with its expression contribute to myocardial infarction risk , 2017, Oncotarget.

[8]  Lei Shi,et al.  Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model , 2016, Oncotarget.

[9]  Yi Li,et al.  Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis , 2017, Current Medical Science.

[10]  F. Sharp,et al.  Altered Expression of Long Noncoding RNAs in Blood After Ischemic Stroke and Proximity to Putative Stroke Risk Loci , 2016, Stroke.

[11]  E. Lander,et al.  Local regulation of gene expression by lncRNA promoters, transcription and splicing , 2016, Nature.

[12]  A. Avan,et al.  The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications. , 2016, Current pharmaceutical design.

[13]  Xiaojun Tang,et al.  Variants in 9p21 Predicts Severity of Coronary Artery Disease in a Chinese Han Population , 2016, Annals of human genetics.

[14]  Howard Y. Chang,et al.  A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation , 2016, Cell.

[15]  H. Schwertz,et al.  Cdkn2a Orchestrates Platelet Production and Reactivity in Atherosclerosis. , 2016, Circulation. Cardiovascular genetics.

[16]  A. Tall,et al.  Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr −/−, Cdkn2a-Deficient Mice , 2016, Circulation. Cardiovascular genetics.

[17]  Y. E. Chen,et al.  Altered long non-coding RNA transcriptomic profiles in brain microvascular endothelium after cerebral ischemia , 2016, Experimental Neurology.

[18]  F. Aguilo,et al.  Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease. , 2015, Current topics in microbiology and immunology.

[19]  O. Franco,et al.  Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium , 2013, PloS one.

[20]  Yan V. Sun,et al.  The cis and trans effects of the risk variants of coronary artery disease in the Chr9p21 region , 2015, BMC Medical Genomics.

[21]  S. Dhanasekaran,et al.  The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.

[22]  G. Can,et al.  Evaluation of association between common genetic variants on chromosome 9p21 and coronary artery disease in Turkish population , 2014, Anatolian journal of cardiology.

[23]  Ming Sun,et al.  Long Noncoding RNA ANRIL Promotes Non–Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression , 2014, Molecular Cancer Therapeutics.

[24]  Ruochi Zhao,et al.  A replication study and a meta-analysis of the association between the CDKN2A rs1333049 polymorphism and coronary heart disease. , 2014, Journal of atherosclerosis and thrombosis.

[25]  M. Steward,et al.  Role of organic osmolytes in water homoeostasis in skin , 2014, Experimental dermatology.

[26]  P. Sharp,et al.  LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint. , 2014, Molecular cell.

[27]  R. Myhre,et al.  Genetic variants in loci 1p13 and 9p21 and fatal coronary heart disease in a Norwegian case-cohort study , 2014, Molecular Biology Reports.

[28]  Clint L. Miller,et al.  Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. , 2014, The Journal of clinical investigation.

[29]  Pankaj Sharma,et al.  Shared Genetic Susceptibility to Ischemic Stroke and Coronary Artery Disease: A Genome-Wide Analysis of Common Variants , 2014, Stroke.

[30]  D. Bartel,et al.  lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.

[31]  M. Caulfield,et al.  Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. , 2012, Human molecular genetics.

[32]  F. Hu,et al.  Variants on Chromosome 9p21.3 Correlated With ANRIL Expression Contribute to Stroke Risk and Recurrence in a Large Prospective Stroke Population , 2012, Stroke.

[33]  Ming-Ming Zhou,et al.  Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. , 2011, Cancer research.

[34]  C. Moy,et al.  Disparities in stroke incidence contributing to disparities in stroke mortality , 2011, Annals of neurology.

[35]  L. Holdt,et al.  Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. , 2011, Atherosclerosis.

[36]  J. Gil,et al.  Epigenetic regulation of the INK4b-ARF-INK4a locus , 2010, Epigenetics.

[37]  R. McPherson,et al.  Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. , 2010, Journal of the American College of Cardiology.

[38]  S. Raguz,et al.  Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. , 2010, Molecular cell.

[39]  Chun-Hua Wang,et al.  Spatio-Temporal Distribution of Inflammatory Reaction and Expression of TLR2/4 Signaling Pathway in Rat Brain Following Permanent Focal Cerebral Ischemia , 2010, Neurochemical Research.

[40]  Bernard Keavney,et al.  Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression , 2010, PLoS genetics.

[41]  G. Schuler,et al.  ANRIL Expression Is Associated With Atherosclerosis Risk at Chromosome 9p21 , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[42]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[43]  G. Peters,et al.  Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.

[44]  L. Wilhelmsen,et al.  Long-Term Risk Factors for Stroke: Twenty-Eight Years of Follow-Up of 7457 Middle-Aged Men in Göteborg, Sweden , 2006, Stroke.

[45]  F. Hashemi,et al.  Corticotropin Releasing Factor (CRF) Activation of NF-κB-Directed Transcription in Leukocytes , 2006, Cellular and Molecular Neurobiology.

[46]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[47]  N. Kalinina,et al.  Smad Expression in Human Atherosclerotic Lesions Evidence for Impaired TGF-β/Smad Signaling in Smooth Muscle Cells of Fibrofatty Lesions , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[48]  S. Lowe,et al.  Tumor suppression by Ink4a-Arf: progress and puzzles. , 2003, Current opinion in genetics & development.